ロード中...

Hexamethylenebisacetamide-induced erythroleukemia cell differentiation involves modulation of events required for cell cycle progression through G1.

Hexamethylenebisacetamide (HMBA), a potent inducer of differentiation of transformed cells such as murine erythroleukemia cells, causes a prolongation of the G1 phase of the cell cycle during which commitment to terminal differentiation is first detected. Removal of HMBA prior to the G1 phase aborts...

詳細記述

保存先:
書誌詳細
主要な著者: Kiyokawa, H, Richon, V M, Venta-Perez, G, Rifkind, R A, Marks, P A
フォーマット: Artigo
言語:Inglês
出版事項: 1993
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC47009/
https://ncbi.nlm.nih.gov/pubmed/8341693
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!